CignaCIEarnings & Financial Report
The Cigna Group is an American multinational for-profit managed healthcare and insurance company based in Bloomfield, Connecticut. Cigna's insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups.
CI Q3 2025 Key Financial Metrics
売上高
$69.7B
粗利益
$14.2B
営業利益
$2.6B
純利益
N/A
粗利益率
20.4%
営業利益率
3.7%
純利益率
N/A
前年比成長
9.5%
EPS
$6.98
資金フロー
Cigna Q3 2025 Financial Summary
Cigna reported revenue of $69.7B for Q3 2025, with a net profit of N/A (N/A margin). Cost of goods sold was $55.5B, operating expenses totaled $11.6B.
Key Financial Metrics
| Total Revenue | $69.7B |
|---|---|
| Net Profit | N/A |
| Gross Margin | 20.4% |
| Operating Margin | 3.7% |
| Report Period | Q3 2025 |
Cigna Annual Revenue by Year
Cigna annual revenue history includes year-by-year totals (for example, 2024 revenue was $247.1B).
| Year | Annual Revenue |
|---|---|
| 2024 | $247.1B |
| 2023 | $195.3B |
| 2022 | $180.5B |
損益計算書
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $51.11B | $57.26B | $60.52B | $63.69B | $65.65B | $65.50B | $67.18B | $69.75B |
| 前年比成長 | 11.7% | 23.1% | 24.6% | 29.9% | 28.4% | 14.4% | 11.0% | 9.5% |
貸借対照表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $152.76B | $153.12B | $155.45B | $157.64B | $155.88B | $150.66B | $151.65B | $157.92B |
| 総負債 | $106.41B | $111.77B | $113.92B | $115.34B | $114.64B | $110.24B | $111.22B | $115.91B |
| 株主資本 | $46.22B | $41.18B | $41.33B | $42.09B | $41.03B | $40.23B | $40.21B | $41.80B |
キャッシュフロー
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 営業CF | $1.47B | $4.84B | $265.0M | $46.0M | $5.21B | $1.92B | $-1.89B | $3.42B |
Other Health Care Companies
CVS
CVS Health
売上高
$105.7B
純利益
$2.9B
DVA
DaVita
売上高
$3.6B
純利益
$234.2M
LH
Labcorp
売上高
$3.6B
純利益
$261.1M
DGX
Quest Diagnostics
売上高
$2.8B
純利益
$245.0M
ABT
Abbott Laboratories
売上高
$11.4B
純利益
$1.6B
ABBV
AbbVie
売上高
$15.8B
純利益
$186.0M
A
Agilent Technologies
売上高
$1.9B
純利益
$434.0M
ALGN
Align Technology
売上高
$995.7M
純利益
$56.8M
AMGN
Amgen
売上高
$9.9B
純利益
$1.3B
BAX
Baxter International
売上高
$3.0B
純利益
$-1.1B